Etiological relationship between lipid metabolism and endometrial carcinoma

Abstract Endometrial carcinoma (EC) has become one of the most common gynecological malignant neoplasms in developed countries worldwide. Studies have shown that this may be closely related to the abnormal metabolism of blood lipids, which was the most significant metabolic change in the human body...

Full description

Bibliographic Details
Main Authors: Wenzhe Li, Yi Xu, Xinling Zeng, Jie Tan, Ya Wang, Hongyan Wu, Maokun Li, Cunjian Yi
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Lipids in Health and Disease
Subjects:
Online Access:https://doi.org/10.1186/s12944-023-01868-2
_version_ 1797451684461412352
author Wenzhe Li
Yi Xu
Xinling Zeng
Jie Tan
Ya Wang
Hongyan Wu
Maokun Li
Cunjian Yi
author_facet Wenzhe Li
Yi Xu
Xinling Zeng
Jie Tan
Ya Wang
Hongyan Wu
Maokun Li
Cunjian Yi
author_sort Wenzhe Li
collection DOAJ
description Abstract Endometrial carcinoma (EC) has become one of the most common gynecological malignant neoplasms in developed countries worldwide. Studies have shown that this may be closely related to the abnormal metabolism of blood lipids, which was the most significant metabolic change in the human body in this cancer. In this review, we focus on the correlation between lipid metabolism and EC and discuss the evidence that abnormal lipid metabolism promotes an increase in EC growth and metabolism, as well as the regulatory mechanism and related signaling pathways involved in this relationship. In addition, we also discussed the research progress of targeted therapies and drug treatments for EC that act on lipid metabolism, and statins are expected to become adjuvant drugs for EC in the future. This review will provide a systematic view for a better understanding of the etiological relationship between lipid metabolism and EC and further open up new therapeutic possibilities and effective treatments for EC by targeting lipid metabolism.
first_indexed 2024-03-09T14:57:04Z
format Article
id doaj.art-5b4daea2a2254aea9513e9c4869e4a5f
institution Directory Open Access Journal
issn 1476-511X
language English
last_indexed 2024-03-09T14:57:04Z
publishDate 2023-08-01
publisher BMC
record_format Article
series Lipids in Health and Disease
spelling doaj.art-5b4daea2a2254aea9513e9c4869e4a5f2023-11-26T14:05:45ZengBMCLipids in Health and Disease1476-511X2023-08-0122111110.1186/s12944-023-01868-2Etiological relationship between lipid metabolism and endometrial carcinomaWenzhe Li0Yi Xu1Xinling Zeng2Jie Tan3Ya Wang4Hongyan Wu5Maokun Li6Cunjian Yi7Department of Endocrinology, The First Affiliated Hospital of Yangtze UniversityDepartment of Endocrinology, The First Affiliated Hospital of Yangtze UniversityDepartment of Gynecology and Obstetrics, The First Affiliated Hospital of Yangtze UniversityDepartment of Hematology, The First Affiliated Hospital of Yangtze UniversityDepartment of Endocrinology, The First Affiliated Hospital of Yangtze UniversityDepartment of Endocrinology, The First Affiliated Hospital of Yangtze UniversityDepartment of Hubei Provincial Clinical Research Center for Personalized Diagnosis and Treatment of Cancer, The First Affiliated Hospital of Yangtze UniversityDepartment of Gynecology and Obstetrics, The First Affiliated Hospital of Yangtze UniversityAbstract Endometrial carcinoma (EC) has become one of the most common gynecological malignant neoplasms in developed countries worldwide. Studies have shown that this may be closely related to the abnormal metabolism of blood lipids, which was the most significant metabolic change in the human body in this cancer. In this review, we focus on the correlation between lipid metabolism and EC and discuss the evidence that abnormal lipid metabolism promotes an increase in EC growth and metabolism, as well as the regulatory mechanism and related signaling pathways involved in this relationship. In addition, we also discussed the research progress of targeted therapies and drug treatments for EC that act on lipid metabolism, and statins are expected to become adjuvant drugs for EC in the future. This review will provide a systematic view for a better understanding of the etiological relationship between lipid metabolism and EC and further open up new therapeutic possibilities and effective treatments for EC by targeting lipid metabolism.https://doi.org/10.1186/s12944-023-01868-2Lipid metabolismEndometrial carcinomaEtiological relationshipStatinsBiological mechanisms
spellingShingle Wenzhe Li
Yi Xu
Xinling Zeng
Jie Tan
Ya Wang
Hongyan Wu
Maokun Li
Cunjian Yi
Etiological relationship between lipid metabolism and endometrial carcinoma
Lipids in Health and Disease
Lipid metabolism
Endometrial carcinoma
Etiological relationship
Statins
Biological mechanisms
title Etiological relationship between lipid metabolism and endometrial carcinoma
title_full Etiological relationship between lipid metabolism and endometrial carcinoma
title_fullStr Etiological relationship between lipid metabolism and endometrial carcinoma
title_full_unstemmed Etiological relationship between lipid metabolism and endometrial carcinoma
title_short Etiological relationship between lipid metabolism and endometrial carcinoma
title_sort etiological relationship between lipid metabolism and endometrial carcinoma
topic Lipid metabolism
Endometrial carcinoma
Etiological relationship
Statins
Biological mechanisms
url https://doi.org/10.1186/s12944-023-01868-2
work_keys_str_mv AT wenzheli etiologicalrelationshipbetweenlipidmetabolismandendometrialcarcinoma
AT yixu etiologicalrelationshipbetweenlipidmetabolismandendometrialcarcinoma
AT xinlingzeng etiologicalrelationshipbetweenlipidmetabolismandendometrialcarcinoma
AT jietan etiologicalrelationshipbetweenlipidmetabolismandendometrialcarcinoma
AT yawang etiologicalrelationshipbetweenlipidmetabolismandendometrialcarcinoma
AT hongyanwu etiologicalrelationshipbetweenlipidmetabolismandendometrialcarcinoma
AT maokunli etiologicalrelationshipbetweenlipidmetabolismandendometrialcarcinoma
AT cunjianyi etiologicalrelationshipbetweenlipidmetabolismandendometrialcarcinoma